Wataya-Kaneda, Mari <br/><br/>
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex : A Randomized Clinical Trial.  [electronic resource] 

 -  JAMA dermatology  01 2017 
 - 39-48 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2168-6084 
<br/><br/><label>Standard No.: </label>10.1001/jamadermatol.2016.3545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Topical<br/>Adolescent<br/>Adult<br/>Angiofibroma--complications<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Child<br/>Double-Blind Method<br/>Facial Neoplasms--complications<br/>Female<br/>Gels<br/>Humans<br/>Male<br/>Middle Aged<br/>Patient Satisfaction<br/>Sirolimus--administration & dosage<br/>Skin Neoplasms--complications<br/>Treatment Outcome<br/>Tuberous Sclerosis--complications<br/>Young Adult